EPISODE · Aug 22, 2025 · 37 MIN
Compass Pathways: Independent Media Talks Psychedelic Medicine
from Divergent States · host Divergent States
In this episode of Divergent States, we sit down with Kabir Nath, CEO of Compass Pathways, and Dr. Steve Levine, Chief Patient Officer, to talk about the future of psychedelic medicine. From FDA approval and insurance coverage to patient access, cultural safety, and patents, we dig into whether Compass is truly disrupting the pharma model or just reinventing it.We also share a major community update: the official Divergent States Discord is now open to all of r/Psychonaut. Built by Brady and the mod team, the server is a space for harm reduction, trip reports, deep dives, and authentic connection across the psychedelic movement.As always, this conversation is about asking the real questions without corporate PR filters. What Compass shared — and what they left unsaid — reveals as much about the future of psilocybin therapy as the answers themselves.👉 Join the movement: connect on Discord, support independent media on Patreon, and be part of the conversation. https://discord.gg/swPwT6ZYunKey PointsFDA approval: path to affordability or illusion of access?COM360 psilocybin therapy: synthetic model, patient journey, and therapy debateAccess & equity: insurance hurdles, pricing models, and patient foundationsCultural safety: trauma-informed design, marginalized populations, indigenous rootsPatents & Pharma tension: innovation vs. corporate control in psychedelic medicineCommunity news: Divergent States Discord officially launches for r/PsychonautChapters 00:00 – Intro: Setting the frame for Compass Pathways 01:30 – Community Update: Divergent States Discord opens for r/Psychonaut 09:30 – Guest Intros: Kabir Nath & Dr. Steve Levine of Compass Pathways 11:20 – Kabir on moving from pharma to psychedelics 12:30 – Steve on ketamine clinics & new models of care 14:15 – What “success” looks like for patients 16:00 – COM360 psilocybin therapy: synthetic vs. natural & the role of therapy 17:30 – How Compass plans to deliver psilocybin in different care settings 18:40 – Patient hopes, fears, and the path to access 20:00 – FDA approval, insurance, and affordability 21:00 – Cultural safety, trauma-informed design, and community input 21:45 – Indigenous engagement & staying “in their lane” 24:15 – The next 5–10 years of psychedelic treatment 26:10 – What could derail psychedelic medicine’s promise 28:10 – Compass’ place in the broader psychedelic ecosystem 29:50 – Outro: Independent media reflections & listener call to action New Music from Sndbagz - check out his new EP "Chosen Path" on Soundcloud and Spotifyhttps://open.spotify.com/artist/0T1LU2nJ9ibGIU3Bxin2X6https://soundcloud.com/user-918755844Send us Fan MailFiresideProject.orgDownload the app or text/call 62-FIRESIDEZendo ProjectOur listeners get 10% off the Zendo Project SIT Program with the code DIVERGENTS10Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showSpecial Thanks to our Macrodosers, Super D and Mike, and our Thumbprint Tier member, Angie on Patreon! https://linktr.ee/3L1T3Mod
What this episode covers
In this episode of Divergent States, we sit down with Kabir Nath, CEO of Compass Pathways, and Dr. Steve Levine, Chief Patient Officer, to talk about the future of psychedelic medicine. From FDA approval and insurance coverage to patient access, cultural safety, and patents, we dig into whether Compass is truly disrupting the pharma model or just reinventing it. We also share a major community update: the official Divergent States Discord is now open to all of r/Psychonaut. Built by Brady and...
NOW PLAYING
Compass Pathways: Independent Media Talks Psychedelic Medicine
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.